A detailed history of Aspire Private Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Aspire Private Capital, LLC holds 102 shares of BDX stock, worth $22,848. This represents 0.01% of its overall portfolio holdings.

Number of Shares
102
Previous 102 -0.0%
Holding current value
$22,848
Previous $23,000 4.35%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$233.45 - $247.73 $15,174 - $16,102
-65 Reduced 38.92%
102 $25,000
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $36,033 - $46,218
167 New
167 $39,000
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $32,680 - $46,594
-167 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$230.58 - $256.08 $1,844 - $2,048
-8 Reduced 4.57%
167 $42,000
Q4 2018

Feb 25, 2019

BUY
$204.73 - $257.93 $32,142 - $40,495
157 Added 872.22%
175 $39,000
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $3,685 - $4,642
18 New
18 $39,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.